Humacyte (HUMA) Stock Highlights

4.64 | +34.1%

2024-12-21 05:00:08

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions.

Statistics

Range Today

4.45 6.77

Volume Today 75.32M

Range 1 Year

2.48 9.97

Volume 1 Year 600.04M

Range 3 Year

1.96 9.97

Volume 3 Year 818.71M

Range 10 Year

1.96 17.45

Volume 10 Year 913.68M

Highlights

Market Capitalization 724.38M (small)

Floating Shares 86.37M

Current Price 4.64

Price To Earnings -3.66

Price To Book 44.12

Earnings Per Share -1.4

Payout Ratio 0%

Performance

Latest +34.1%

1 Month +6.67%

3 Months -14.71%

6 Months -18.74%

1 Year +56.23%

3 Years -47.09%

5 Years -52.16%

10 Years -52.16%

Benchmarks

Market Capitalization

174 / 368

Gross Profits

0 / 278

Total Revenue

294 / 300

Total Rank

322 / 368

Free Cashflow

207 / 352

Performance 5 years

171 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.